{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:19:39Z","timestamp":1782278379170,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","pregnancyhypertension.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.preghy.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T10:49:49Z","timestamp":1488365389000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1\/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor\u00ae"],"prefix":"10.1016","volume":"8","author":[{"given":"Lisa Antonia","family":"Dr\u00f6ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Verlohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Holger","family":"Perschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. A","key":"10.1016\/j.preghy.2017.02.005_b0005","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2017.02.005_b0010","series-title":"World Health Report: Make Every Mother and Child Count","author":"WHO","year":"2005"},{"key":"10.1016\/j.preghy.2017.02.005_b0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the national high blood pressure education program working group on high blood pressure in pregnancy","volume":"183","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/ror.0.0010107","article-title":"The vascular endothelium in normal pregnancy and pre-eclampsia","volume":"1","author":"Lyall","year":"1996","journal-title":"Rev. Reprod."},{"issue":"Suppl. 3","key":"10.1016\/j.preghy.2017.02.005_b0025","first-page":"332","article-title":"Intrauterine growth retardation (IUGR): epidemiology and etiology","volume":"6","author":"Romo","year":"2009","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.preghy.2017.02.005_b0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2017.02.005_b0035","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preghy.2017.02.005_b0045","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0050","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"06","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0055","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2017.02.005_b0060","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJMoa1414838","article-title":"The sFlt-1\/ PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2017.02.005_b0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2017.02.005_b0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/uog.14760","article-title":"Maternal serum sFlt-1\/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies","volume":"45","author":"Dr\u00f6ge","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0075","unstructured":"S1-Leitlinie Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen 12\/2013, http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/015-018.html (accessed 01.09.2016)."},{"issue":"1","key":"10.1016\/j.preghy.2017.02.005_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/PRG-100104165","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens. Pregn."},{"key":"10.1016\/j.preghy.2017.02.005_b0085","article-title":"Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study","volume":"4","author":"Unterscheider","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.02.005_b0090","first-page":"1","article-title":"Kryptor-automated angiogenic factor assays and the risk of preeclampsia-related adverse outcomes","volume":"30","author":"Salahuddin","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2017.02.005_b0095","doi-asserted-by":"crossref","first-page":"862015","DOI":"10.1016\/j.jash.2014.11.008","article-title":"Diagnosis of preeclampisa with soluble Fms-like tyrosine kinase 1\/placental growth factor ratio: an inter-assay comparison","volume":"9","author":"Andersen","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.preghy.2017.02.005_b0100","first-page":"111","article-title":"Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia","volume":"16\u201317","author":"Van Helden","year":"2015","journal-title":"Clin. Biochem."}],"container-title":["Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778916304111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778916304111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:23:12Z","timestamp":1536002592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778916304111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"alternative-id":["S2210778916304111"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2017.02.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1\/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor\u00ae","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}